Abstract:This study presents a paclitaxel (PTX) based polymeric prodrug (FCPTX) using functionalized Pluronic-b-poly(epsilon-caprolactone) bearing carboxyl groups [pluronic-b-poly(epsilon-caprolactone-co-6-carboxylic-s-caprolactone), Pluronic-b-P(CL-co-CCL), FC] as the substrate by a dicyclohexylcarbodiimide/4-dimethylaminopyridine-catalyzed (DCC/DMAP-catalyzed) esterification reaction. High Performance Liquid Chromatography (HPLC) and H-1 NMR. were employed together to prove the successful reaction and confirmed the structure and composition of FCPTX. The result revealed that the 2'-OH of PTX participated in reaction and the PTX content in FCPTX was up to 18.3 wt%. The polymeric prodrug could self-assemble into micelles via an emulsion/solvent evaporation technique. Furthermore, the micelle was used as the nanomicellar carrier for delivery of free PTX. TEM and DLS were used to study the size and morphologies of the FCPTX micelles and PTX-loaded FCPTX (PTX/FCPTX) micelles. The results demonstrated that the two micelles were spherical spheres with narrow distribution and the size of PTX/FCPTX micelles was larger than that of FCPTX micelles due to the micellar core was enlarged by the loaded drug. The drug loading content (DLC) and drug loading efficiency (DLE) demonstrated that the great drug loading capability of FCPTX for free PTX which could be attributed to the fact that the excellent compatibility between drug and micellar core. The sustained in vitro release of PTX/FCPTX was due to that the forceful intermolecular interaction between conjugated PTX on the polymer and the encapsulated PTX, also, the forceful intermolecular interaction led to the high residual of PTX (only 33.0% total release after 72 h at pH 7.4). However, in the lower pH environment, the drug release was accelerated due to hydrolysis of ester bond and disaggregation of micelles. In vitro antitumor experiments showed that the cytotoxicity of the conjugated PTX was reduced due to that the 2'-OH of PTX was reacted and the drug activity was crippled. The PTX/FCPTX micelles revealed high antitumor activity due to the high cellular accumulation by micelle delivery. Subsequently, the great blood compatibility of FCPTX micelles and PTX/FCPTX micelles were obtained. All of the results demonstrated the use of the polymeric conjugated PTX as the core of the polymericrnicelles afforded an ideal affinity site for free PTX and had a marvelous potential in combination chemotherapy.

Paclitaxel prodrug nanoparticles combining chemical conjugation and physical entrapment for enhanced antitumor efficacy

Paclitaxel-Paclitaxel Prodrug Nanoassembly As A Versatile Nanoplatform for Combinational Cancer Therapy

Acetal-linked PEGylated Paclitaxel Prodrugs Forming Free-Paclitaxel-loaded Ph-Responsive Micelles with High Drug Loading Capacity and Improved Drug Delivery.

Self-assembly of oxidation-responsive polyethylene glycol-paclitaxel prodrug for cancer chemotherapy

Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy.

Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.

Co-delivery of Paclitaxel and Doxorubicin Using Mixed Micelles Based on the Redox Sensitive Prodrugs.

Co-Delivery of Paclitaxel by a Capsaicin Prodrug Micelle Facilitating for Combination Therapy on Breast Cancer

Porphyrin Centered Paclitaxel Tetrameric Prodrug Nanoassemblies as Tumor‐Selective Theranostics for Synergized Breast Cancer Therapy

Novel free paclitaxel-loaded poly(L-γ-glutamylglutamine)-paclitaxel nanoparticles.

Synchronized Delivery of Dual-Drugs for Potentiating Combination Chemotherapy Based on Smart Triple-Responsive Polymeric Micelles

A Prodrug Strategy to Deliver Cisplatin(Iv) and Paclitaxel in Nanomicelles to Improve Efficacy and Tolerance

Enzyme-Sensitive and Amphiphilic PEGylated Dendrimer-Paclitaxel Prodrug-Based Nanoparticles for Enhanced Stability and Anticancer Efficacy

Dendrimer-based Multilayer Nanocarrier for Potential Synergistic Paclitaxel–doxorubicin Combination Drug Delivery

Paclitaxel prodrug nanoparticles boost antitumor efficacy via hitchhiking of human serum albumin

Superior Antitumor Effect of Self-Assembly Supramolecular Paclitaxel Nanoparticles

Synthesis and Properties of the Poly(ε-caprolactone)-paclitaxel Prodrug

Well-defined Polymer-Drug Conjugate Engineered with Redox and Ph-Sensitive Release Mechanism for Efficient Delivery of Paclitaxel.

Enhanced in vivo Stability and Antitumor Efficacy of PEGylated Liposomes of Paclitaxel Palmitate Prodrug

Novel free paclitaxel-loaded poly(L-&gamma;-glutamylglutamine)&ndash;paclitaxel nanoparticles

Synthesis and Characterization of a New Multifunctional Polymeric Prodrug Paclitaxel–polyphosphoester–folic Acid for Targeted Drug Delivery